HOME >> BIOLOGY >> NEWS
Prozac's target revealed

Researchers at Cold Spring Harbor Laboratory on Long Island have identified which among several different kinds of cells in the brain is the chief target of the widely prescribed antidepressant Prozac. This discovery might enable a new generation of more specific treatments for depression, with fewer side effects, to be developed.

The findings also lay the foundation for many studies of the factors that control how, when, and where new neurons are generated from stem cells in the brain. Such work could eventually lead to cell replacement therapies for neurodegenerative and other brain disorders including Alzheimer's and Parkinson's disease.

It has been known for some years that Prozac (fluoxetine) is likely to relieve the symptoms of depression by somehow causing more neurons to be present in a particular region of the brain (the "dentate gyrus"). But the origins of these neurons, and how Prozac promotes their existence, have been a mystery until now.

By profiling the telltale marker proteins produced by different kinds of cells in the brains of adult mice, the researchers first defined discrete steps in the complex process, called neurogenesis, that converts unspecialized stem cells into mature, specialized neurons.

Next, knowing that Prozac treatment somehow increases the number of neurons in the brain, the researchers tested which step in the neurogenesis pathway might be stimulated by Prozac. They found that Prozac treatment specifically stimulates the generation of a kind of cells they dubbed "amplifying neural progenitors" or ANPs--the second step in the neurogenesis pathway from stem cells to mature neurons. (Illustration available on request)

The study is published in the published in the Proceedings of the National Academy of Sciences (advance on-line this week, in print on May 23). It was led by Grigori Enikolopov and spearheaded by postdoctoral fellow Juan Manuel Encinas.

To address the controversy surroundi
'"/>

Contact: Peter Sherwood
sherwood@cshl.edu
516-367-6947
Cold Spring Harbor Laboratory
15-May-2006


Page: 1 2

Related biology news :

1. Huntingtons disease study shows animal models on target
2. New target for HIV/AIDS drugs and vaccine discovered
3. When off-target is right on
4. Genomic analysis uncovers new targets for HIV vaccine
5. Bulls-eye -- Programs targeting math, science teacher shortage may get boost
6. Scientists take next step in understanding potential target for ovarian cancer treatment
7. On target
8. New way to target and kill antibiotic-resistant bacteria found
9. Weill Cornell team identifies potential new cancer drug target
10. CSHL scientists successfully target tumor microenvironment to stop cancer growth
11. Sleep deprivation affects airport baggage screeners ability to detect rare targets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... Nanomedical Diagnostics , ... new publication titled, “ Graphene-based Biosensor for On-Chip Detection of Bio-Orthogonally Labeled Proteins ... as a “new portable digital device for biosensing… that can be employed for ...
(Date:10/11/2018)... ... October 09, 2018 , ... ? ... market-ready technologies expedite their path to health system adoption and insurer reimbursement, ? ... across all major EHR applications, enabling them to focus on innovation not integration, ...
(Date:10/11/2018)... ... October 11, 2018 , ... ODSC Europe 2018 - ... 100% increase in attendance at the event from September 19-22. , As Europe’s ... intelligence sessions across 10 tracks and 4 days. Attendees were given key insights and ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... (PRWEB) , ... October 02, 2018 , ... ... and Locus Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was chosen for ... Oil and Gulf Energy Information, honor leading innovations in upstream oil applications that ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... this week that teams have initiated validation of standards and testing of procedures ... direction of Dr. Larry Kennedy, ACRES VP for Quality Management Systems and Chief ...
(Date:9/28/2018)... ... September 28, 2018 , ... ... to increase the availability of the GlycoMark test, the only FDA-cleared blood test ... the partnership, PMLS will promote and offer the GlycoMark test to its network ...
(Date:9/27/2018)... ... 26, 2018 , ... NDA Partners Chairman Carl Peck, ... and in vitro diagnostic device expert with more than 28 years of experience ... as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality ...
Breaking Biology Technology:
Cached News: